The new ILAP TDP: De-risking development by bringing early insights, predictability and improved coordination for developers
The refreshed Innovative Licensing and Access Pathway (ILAP) is setting a new global benchmark for accelerating patient access to transformative medicines in the UK. More than just a regulatory pathway, the ILAP is the first end-to-end access pathway that brings …